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Abstract
Background: High-quality, cause-specific mortality data are critical for effective health policy. Yet vague cause of
death codes, such as heart failure, are highly prevalent in global mortality data. We propose an empirical method
correcting mortality data for the use of heart failure as an underlying cause of death.
Methods: We performed a regression analysis stratified by sex, age, and country development status on all
available ICD-10 mortality data, consisting of 142 million deaths across 838 country-years. The analysis yielded
predicted fractions with which to redistribute heart failure-attributed deaths to the appropriate underlying causes
of death. Age-adjusted death rates and rank causes of death before and after correction were calculated.
Results: Heart failure accounts for 3.1% of all deaths in the dataset. Ischemic heart disease has the highest
redistribution proportion for ages 15-49 and 50+ in both sexes and country development levels, causing gains in
age-adjusted death rates in both developed and developing countries. COPD and hypertensive heart disease also
make significant rank gains. Reproductive-aged women in developing country-years yield the most diverse range
of heart failure causes.
Conclusions: Ischemic heart disease becomes the No. 1 cause of death in several developed countries, including
France and Japan, underscoring the cardiovascular epidemic in high-income countries. Age-adjusted death rate
increases for ischemic heart disease in low- and middle-income countries, such as Argentina and South Africa,
highlight the rise of the cardiovascular epidemic in regions where public health efforts have historically focused on
infectious diseases. This method maximizes the use of available data, providing better evidence on major causes of
death to inform policymakers in allocating finite resources.
Introduction
Accurate cause of death data are critical to developing
an effective health policy agenda. Just as clinicians must
accurately diagnose patients before prescribing treat-
ment, policymakers must assess population-level disease
burden in order to prioritize health interventions [1].
Despite this, the availability of high-quality, cause-speci-
fic mortality data is limited [2-6]. Even for countries
with high vital registration coverage, the quality of the
data is often substandard [2,4-7]. Using the heart failure
cause of death code as a case study, this article proposes
a method to improve the quality of vital registration
mortality data to provide policymakers with more accu-
rate diagnostic datasets from which to prioritize health
interventions.
In mortality data analysis, the underlying cause of
death is of greatest importance [8,9]. The World Health
Organization (WHO) defines the underlying cause of
death as “the disease or injury which initiated the train
of morbid events leading directly to death, or the cir-
cumstance of the accident or violence which produced
the fatal injuries” [8]. The underlying cause must satisfy
two criteria fundamental to this definition. Specifically,
the underlying cause must be the primary or initial
cause such that it represents a logical stage of interven-
tion to prevent death, while retaining its status as a dis-
ease or injury to which death can be definitively
assigned. One of the most significant barriers to
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nonspecific cause of death codes, such as those for heart
failure. These ambiguous or vague codes were first
described as “garbage codes” in the Global Burden of Dis-
ease (GBD) 1990 study, in reference to ill-defined cardio-
vascular, malignancy, and injury codes [2]. A recent
paper by Naghavi et al stresses that garbage codes nega-
tively impact the public health utility of cause of death
data [10]. This problem stems from the fact that the
International Classification of Diseases (ICD), the coding
scheme used in most countries with vital registration sys-
tems, contains many codes that signify signs, symptoms,
and conditions, or intermediate and immediate causes of
death [9]. These codes are often misrecorded as an
underlying cause of death on death certificates or in mor-
tality datasets for a number of reasons [11-15]. Physicians
do not always have access to accurate or complete medi-
cal records from which to determine the correct underly-
ing cause of death [6,15,16]. They may be inadequately
trained to complete death certificates [17], or, in some
cases, may intentionally miscode deaths in the face of
political, financial, or social pressure (i.e., HIV-related
stigma). In developing nations, these realities are com-
pounded by the fact that only a small percentage of death
certificates are completed by physicians [15].
Heart failure is the end stage of many cardiac and
noncardiac pathological processes, from ischemic heart
disease and the range of cardiomyopathies to respiratory
disease and severe anemia. As such, heart failure is not
an underlying cause of death according to the WHO
definition, but rather an intermediate cause of death
with a diverse range of possible underlying causes of
death. The use of heart failure as an underlying cause of
death code leads to a vague and sometimes inaccurate
representation of the population-level causes of death
[2,18]. Because prevention, detection, and treatment
efforts for severe anemia and ischemic heart disease are
different, it is essential for policymakers to know the
true etiology of heart failure-attributed deaths. [Please
note that for the rest of the paper, the term “heart fail-
ure-attributed deaths” refers solely to deaths in which
heart failure was attributed as the underlying cause of
death and not deaths in which heart failure is coded as
a complication of the underlying cause in Part I of the
death certificate or contributory causes in Part II of the
death certificate.] In fact, Naghavi et al defines garbage
codes, of which heart failure is most frequent, as “all
deaths assigned to codes that should be redistributed to
enhance the validity of public health analysis” [10]. A
process called heart failure redistribution, in which heart
failure-attributed deaths in existing mortality data are
reallocated to the correct underlying causes of death,
can accomplish this.
Though the problem of miscoded mortality data is
appreciated in the literature [2-6,10,12,14-20], there is a
paucity of redistribution methods described in the litera-
ture. Two methods used in the GBD literature are out-
lined below. GBD 1990 and 2001 redistributed
aggregated groups of ill-defined cardiovascular codes
(heart failure, atherosclerosis, essential hypertension,
etc.) to one underlying cause of death, ischemic heart
disease [2,4,18]. Less specific garbage codes, such as
“other ill-defined, and unspecified causes of mortality
(ICD-10, R99),” have been redistributed proportionally
across all-cause mortality [2].
Building on these previous approaches, this paper
describes in detail a novel method to carry out heart fail-
ure redistribution. This method was employed, but not
described, in Naghavi’sr e c e n tw o r k[ 1 0 ] .T h em e t h o d
redistributes from a single garbage code - heart failure - to
multiple underlying causes of death while accounting for
the fact that clinicians miscode heart failure deaths at rates
disproportionate to the relative prevalence of its plausible
underlying causes. It is important to note here that this
method does not redistribute heart failure-attributed
deaths proportionally across the underlying causes, a
method that has been used in the past. We then compare
cause of death patterns on a pre- and post-redistribution
mortality dataset to show the effect of heart failure redis-
tribution on age-adjusted death rates and cause of death
rankings for the leading causes of death in 2005.
Methods
Data
The mortality data used in our model are a combination
of the Sept. 8, 2009 version of the WHO mortality data-
base [21] and additional country-years obtained by the
Institute for Health Metrics and Evaluation. No primary
data were collected for this study and all data were com-
pletely anonymous. Using the ICD coding scheme and
listed by country-year, the WHO mortality database is a
publicly available dataset listing the number of underly-
ing deaths due to each ICD code stratified by age and
sex. The additional country-year data used in the model
are formatted in a similar manner. Country-years used
in the model were restricted to ICD-10, the most recent
iteration of the ICD. The dataset used in the model con-
sists of 141,940,984 deaths across 838 country-years ran-
ging from 1994-2007, representing 115 countries and 17
of the 21 GBD 2005 regions. [Additional file 1 lists each
of the countries in the dataset by GBD region, specifying
the number and range of country-years.]
Heart failure in the International Classification of Diseases
Heart failure is defined as the following ICD-10 codes:
I50, I50.0, I50.1, I50.9:
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￿ I50.0 Congestive heart failure
￿ I50.1 Left ventricular failure
￿ I50.9 Heart failure, unspecified
Because the ICD-10 is structured in increasing levels
of specificity, I50 is a three-character code that encom-
passes each of the corresponding four-character codes.
Most country-years in the dataset list deaths at the
four-character level. Some country-years employ a les-
ser degree of specificity and list deaths at the three-
character level. In this analysis, we have aggregated
I50.0, I50.1, and I50.9 into one code and treated it as
I50. Attempts to analyze codes at the four-character
level yielded no significant differences. [Additional file
1 includes a column that describes, by country, the
percentage of all heart failure-attributed deaths
assigned to I50.9 for countries that list deaths at the
four-character level.]
Defining the target list
A list of potential underlying causes of death to which
heart failure may be redistributed, known as targets,
was chosen. This ap r i o r iconceptual decision was
rooted in the pathophysiology of heart failure. We iden-
tified 49 causes at the three-character, ICD version 10
level. One four-character code was included in target
group 10, I31.1 chronic constrictive pericarditis. The 49
causes are aggregated into 12 target groups on the basis
of heart failure pathophysiology. The target groups are
as follows:
￿ TG1 - Aortic aneurysm
￿ TG2 - Chronic obstructive pulmonary disease
(COPD)
￿ TG3 - Cardiomyopathy
￿ TG4 - Chronic severe anemia
￿ TG5 - Congenital heart anomalies
￿ TG6 - Hypertensive heart disease
￿ TG7 - Ischemic heart disease
￿ TG8 - Other respiratory diseases
￿ TG9 - Other valve diseases
￿ TG10 - Pericarditis, endocarditis, myocarditis
￿ TG11 - Rheumatic heart disease
￿ TG12 - Thyroid disorders
Table 1 is a list of target groups used in this model
and their corresponding ICD-10 codes. This target list is
globally representative and does not include key regional
causes, such as Chagas disease in Latin America, an
important factor to consider in redistributing regional
mortality datasets.
Table 1 Heart failure target list, by group
Target Group
1
Aortic Aneurysm
I71 Aortic aneurysm and dissection
Target
Group 2
COPD
J43 Emphysema
J44 Other chronic obstructive pulmonary disease
Target
Group 3
Cardiomyopathy
I42 Cardiomyopathy
Target
Group 4
Chronic Severe Anemias
D50 Iron deficiency anemia
D55 Anemia due to enzyme disorders
D56 Thalassemia
D57 Sickle-cell disorders
D58 Other hereditary hemolytic anemias
D59 Acquired hemolytic anemia
Target
Group 5
Congenital Heart Anomalies
Q20 Congenital malformations of cardiac chambers and
connections
Q21 Congenital malformations of cardiac septa
Q22 Congenital malformations of pulmonary and tricuspid
valves
Q23 Congenital malformations of aortic and mitral valves
Q24 Other congenital malformations of heart
Q25 Congenital malformations of great arteries
Target
Group 6
Hypertensive heart disease
I11 Hypertensive heart disease
I12 Hypertensive renal disease
I13 Hypertensive heart and renal disease
Target
Group 7
Ischemic Heart Disease
I21 Acute MI
I22 Subsequent MI
I23 Certain current complications following acute MI
I24 Other acute ischemic heart diseases
I25 Chronic ischemic heart disease
Target
Group 8
Other Respiratory Diseases
J60 Coalworker’s pneumoconiosis
J61 Pneumoconiosis due to asbestos or other mineral
fibers
J62 Pneumoconiosis due to dust containing silica
J63 Pneumoconiosis due to other inorganic dusts
J64 Unspecified pneumoconiosis
J65 Pneumoconiosis associated with tuberculosis
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The unit of interest in the model is a country’sv i t a l
registration system in a given year. Within each coun-
try-year, we are interested in the deaths related to
heart failure, known as the heart failure universe
deaths. The heart failure universe is defined as heart
failure-attributed deaths (I50 or I50.0, I50.1, I50.9)
and all possible targets included in the regression
(Table 1), and is used as the denominator for the
regression variables. The equation for the heart failure
universe is as follows:
Each country-year will occupy a specific point along a
spectrum, from all target group-attributed and no heart
failure-attributed deaths (an ideal country-year) to no
target group-attributed and all heart failure-attributed
deaths (the worst-case scenario). Separate linear regres-
sions were run for each target group to estimate the
relationship across country-years between the propor-
tion of heart failure-attributed deaths and the propor-
tion assigned to each target group within the heart
failure universe:
%TG = a + b[%HF] + ε, where
%HF = Heart failure - attributed deaths/HF universe deaths
%TG = Target group - attributed deaths/HF universe deaths
A l la n a l y s i sw a sr u ni nS T A T Av e r s i o n1 0 . 1 S E .
Separate regressions were run for each sex and for the
following three age groups within each sex: 0-14, 15-49,
50+. Country-years were grouped into regions based on
the GBD 2005 regions, and regions were stratified as
developed or developing in accordance with the World
Development Indicators 2008 [22]. Table 2 shows the 21
GBD regions stratified by development status. There
were 338 developed country-years and 500 developing
country-years used in the model. After the initial regres-
sion was run, target groups with statistically significant
(p < 0.05) positive betas were dropped from the analysis.
In these cases, the model made a statistical selection of
the possible target groups previously chosen on the
conceptual basis of heart failure pathophysiology. [Addi-
tional file 2 describes the interpretation of the regression
results and the decision to drop specified targets.] By
dropping a target, the heart failure universe decreases in
size. The regression was rerun with the revised target
group list and thus the smaller heart failure universe to
ensure no changes in statistical significance in the
revised heart failure universe. The process was repeated
a second time. Ultimately, the constant values (y-inter-
cept) yielded by the regression predict an ideal, all-
target, no-garbage universe. The constant values for the
target groups with statistically significant (p < 0.05)
Table 2 Global Burden of Disease 2005 Regions, by
development status
Developed Developing
Asia Pacific, High Income Asia, Central
Australasia Asia, East
Europe, Central Asia, South
Europe, Western Asia, Southeast
North America, High Income Caribbean
Europe, Eastern
Latin America, Andean
Latin America, Central
Latin America, Southern
Latin America, Tropical
North Africa / Middle East
Oceania
Sub-Saharan Africa, Central
Sub-Saharan Africa, East
Sub-Saharan Africa, Southern
Sub-Saharan Africa, West
**A detailed list of GBD region country lists can be found in the GBD 2005
Operations Manual http://www.globalburden.org/gbdops.html.
Table 1 Heart failure target list, by group (Continued)
Target
Group 9
Other valve diseases
I34 Non-rheumatic mitral valve disorders
I35 Non-rheumatic aortic valve disorders
I36 Non-rheumatic tricuspid valve disorders
I37 Pulmonary valve disorders
Target
Group 10
Pericarditis, endocarditis, myocarditis
I33 Acute and subacute endocarditis
I40 Acute myocarditis
I31.1 Chronic constrictive pericarditis
Target
Group 11
Rheumatic Heart Disease
I05 Rheumatic mitral valve diseases
I06 Rheumatic aortic valve diseases
I07 Rheumatic tricuspid valve diseases
I08 Multiple valve diseases
Target
Group 12
Thyroid Disorders
E00 Congenital iodine-deficiency syndrome
E01 Iodine-deficiency-related thyroid disorders and allied
conditions
E02 Subclinical iodine-deficiency hypothyroidism
E03 Other hypothyroidism
E04 Other nontoxic goiter
E05 Thyrotoxicosis [hyperthyroidism]
E06 Thyroiditis
E07 Other disorders of thyroid
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redistribution proportions.
Applying the redistribution proportions
Using the 2005 mortality data from the dataset, the
redistribution proportions estimated by the above
regression model were employed to redistribute all heart
failure-attributed deaths to the appropriate target
groups. Heart failure-attributed deaths for developed
country adolescents (ages 0-14), for which no redistribu-
tion proportions were estimated, were redistributed to
congenital heart anomalies. From the revised target
groups, deaths were redistributed to the ICD-level
causes comprising that target group, based on the rela-
tive prevalence of the ICD-level cause within that target
group.
These corrected ICD-level causes were aggregated into
GBD 2005 cause groups, and age-adjusted death rates by
GBD cause were calculated on the pre- and post-redis-
tribution datasets. Percentage change in age-adjusted
death rate was calculated by cause. GBD-level causes of
death were ranked by age-adjusted death rate in the
pre- and post-heart failure redistribution datasets.
Table 3 outlines the seven major steps of the model
and highlights assumptions at pertinent steps.
Results
Heart failure-attributed deaths comprise approximately
4.35 million deaths (3.1%) of the 142 million deaths in
the dataset. Table 4 describes heart failure-attributed
deaths by group in the dataset. Heart failure-attributed
deaths are greater in older age groups and in developed
country-years. Females from developed countries aged
50+ have the most heart failure-attributed deaths, with
36.9% of all heart failure-attributed deaths in the dataset.
I nt h e1 5 - 4 9a g eg r o u p ,t h e r ea r em o r eh e a r tf a i l u r e -
attributed deaths in developing country-years than in
developed country-years - 4.7% and 1.1% of all heart
failure-attributed deaths, respectively.
Figures 1 and 2 show a series of eight pie charts dis-
playing the redistribution proportions estimated by the
regression by sex and country development level for
ages 15-49 and 50+. The proportions represent the frac-
tion of heart failure-attributed deaths from that age-sex-
country development group that should be redistributed
to the specified target groups. Based on the statistical
selection of targets in the model, certain target groups
are not chosen for redistribution (b >0 ,b ~0) for a
given age-sex-country development group and are not
found in the pie charts.
With 93.1% of all heart failure deaths in the dataset,
the 50+ age group has the highest number of heart fail-
ure-attributed deaths. The model estimates that
ischemic heart disease is the most important target
group across both sex and country development stratifi-
cations in this age group. Collectively, ischemic heart
disease has a higher redistribution proportion within the
developed country-years compared to the developing
country-years. [Additional file 3 displays the complete
regression results for each target group for developing
country males aged 50+.] Hypertensive heart disease is a
redistribution target for both sexes in developing coun-
try-years (males = 0.104, females = 0.148) but is not a
target in developed country-years.
With nine of the 12 targets being redistributed upon,
the model predicts that developing country females of
Table 3 Steps in redistribution of heart failure (HF)
Details of step Assumptions of step
Step 1 define pathophysiologically plausible target list at ICD level
(these targets will ultimately receive redistributed HF deaths)
that only pathophysiologically plausible deaths are miscoded as HF
Step 2 group ICD-level causes into target groups of related causes
1
Step 3 choose representative mortality dataset (can be multinational
or national depending on the population being examined)
that deaths coded to heart failure targets were correctly assigned
Step 4 use regression (%TG = a + b[%HF] + ε) to define redistribution
proportions for each cause, by age-sex-development group
2
that deaths miscoded as heart failure are miscoded at rates
disproportionate to the relative prevalence of the underlying causes of
heart failure
Step 5 redistribute deaths from HF to each target group by age-sex-
development group within target mortality dataset
Step 6 redistribute deaths from target group level to ICD cause level
using proportionate redistribution
3 within target mortality
dataset
Step 7 use revised mortality dataset to calculate desired outcome
measure [age-adjusted death rates, rank causes of death, etc.]
that there is no need to correct primary mortality dataset for
completeness
4
1table 1 shows the groups defined in this paper.
2details of regression found in methods section and in additional file 2.
3in proportionate redistribution, redistributions proportions are defined by the relative prevalence of the cause within the target group.
4see discussion for an explanation of this assumption.
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targets in comparison to all other age-sex-country devel-
opment groups. This is the only group that has the fol-
lowing targets: chronic severe anemias, thyroid
disorders, and rheumatic heart disease.
Redistributing heart failure using the above redistribu-
tion proportions on 2005 global mortality data provides
the opportunity to assess the magnitude of change
between a pre- and post-redistributed dataset. Figure 3
shows age-adjusted death rates for ischemic heart dis-
ease before and after heart failure redistribution for a
selection of 10 countries. Age-adjusted death rates for
ischemic heart disease are seen to be uniformly greater
for males than females in both developed and develop-
ing countries. Argentine and South African males have
the greatest absolute increase in age-adjusted death
rates at 50 and 48 deaths per 100,000, respectively. This
increase puts the age-adjusted death rate for South Afri-
can males in the range of developed nations - two
deaths greater per 100,000 than the United Kingdom
and two deaths fewer per 100,000 than the US. With a
greater than twofold increase, age-adjusted death rates
for ischemic heart disease among South African females
surpass several developed countries, including Germany,
the US, and the United Kingdom.
Figure 4 shows the percentage increase in age-
adjusted death rates for pertinent causes in the group
with the most diverse range of heart failure target
groups - developing country women. This figure shows
significant increases in heart failure causes associated
strongly with pregnancy, including iron deficiency ane-
mia and cardiomyopathy, a target inclusive of peripar-
tum cardiomyopathy.
Table 5 shows a selection of countries in which there
was a change in rank for the leading causes of death
after heart failure redistribution. In France, ischemic
heart disease surpasses cancer to become the top-ranked
cause of death. In Japan, ischemic heart disease rises
from the No. 3 to the No. 1 cause of death for men and
No. 2 for women. Developing countries, such as Argen-
tina and South Africa, see several important rank
increases for hypertensive heart disease and COPD.
Figure 1 Redistribution proportions by target group, females. This series of pie charts displays the target groups, or underlying causes, for
females by age and country development group that heart failure-attributed deaths are redistributed to and the proportion that each target
group receives, as predicted by the regression model.
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No. 3, displacing Alzheimer’s disease.
Discussion
The use of heart failure as a cause of death code com-
plicates the understanding of the major underlying
causes of heart failure, resulting in a misallocation of
limited health resources to prevent, detect, and treat
those underlying conditions. Despite the WHO’s
recommendation to not use heart failure as an underly-
ing cause of death, heart failure constitutes a consider-
able portion of global deaths and, as such, the
redistribution of heart failure deaths to the appropriate
underlying causes has a significant impact on causes of
death at the population level. The benefit of the regres-
sion utilized in this model when compared to past mod-
els is that by comparing coding practices across
country-years, it accounts for the fact that heart failure-
attributed deaths are miscoded at rates disproportionate
to the relative prevalence of its underlying causes.
Consistent with the epidemiology of heart failure dis-
cussed in the literature [23-28], ischemic heart disease
has the highest redistribution proportion for adults in
all sex and country development stratifications. In devel-
oping countries such as South Africa, the significant
increases in age-adjusted death rates highlight the epide-
miologic transition, whereby disease burden shifts from
communicable to noncommunicable diseases as
Figure 2 Redistribution proportions by target group, males. This series of pie charts displays the target groups, or underlying causes, for
males by age and country development group that heart failure-attributed deaths are redistributed to and the proportion that each target
group receives, as predicted by the regression model.
Table 4 Heart failure-attributed deaths by age, sex,
development group, in thousands [percent of all heart
failure deaths]
Ages 0-14 Ages 15-49 Ages > 50
DEVELOPED Males 1.2 [< 0.1] 34.6 [0.8] 981.5 [22.6]
Females 1 [< 0.1] 13.7 [0.3] 1602.8 [36.9]
DEVELOPING Males 24.6 [0.6] 129.1 [3.0] 704.8 [16.2]
Females 20.8 [0.5] 74.5 [1.7] 758.1 [17.4]
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Page 7 of 11Figure 3 Age-adjusted death rates (per 100,000) in 2005 for ischemic heart disease before and after heart failure redistribution, by
country. This graph shows the increase in age-adjusted death rates for ischemic heart disease for males and females in a series of 10 countries
after redistribution of heart failure using the redistribution proportions predicted by the regression model, described in the preceding pie charts.
Figure 4 Percent increase in age-adjusted death rate in 2005 in developing countries by cause, females. This graph depicts the increase
in age-adjusted death rates for several cardiac and noncardiac underlying causes of heart failure after the redistribution of heart failure-attributed
deaths, using the redistribution proportions predicted by the regression model, for females in developing countries.
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oped countries where ischemic heart disease was not
already the No. 1 cause of death, such as France and
Japan, it became the top killer after heart failure redistri-
bution. The relative increase in the age-adjusted death
rate of ischemic heart disease in France - by 55% for
women and 35% for men - prompts questions about the
validity of the French paradox, an analysis using coron-
ary heart disease as the cause of death variable without
accounting for heart failure-attributed deaths [30].
Finally, even in countries such as the United Kingdom,
with previously documented low miscoding rates [31],
there is a notable increase in age-adjusted death rates.
T h er i s eo fh y p e r t e n s i v eh e a r td i s e a s ei nd e v e l o p i n g
country-years is likely due to a combination of the
increasing burden of hypertension in developing nations
coupled with the relative decreased access to antihyper-
tensive medication in the developing world [32-34].
COPD is recognized in the literature as the most com-
mon cause of cor pulmonale [35], heart failure second-
ary to pulmonary disease, and represents the most
significant noncardiac target for redistribution. The rank
increases for hypertensive heart disease and COPD
should bolster resources for hypertension control and
pulmonary disease, with the latter an often-overlooked
underlying cause of heart failure.
The complex epidemiological profile of reproductive-
aged women (ages 15-49) in developing countries
accounts for the most diverse range of heart failure tar-
gets compared to all other groups. In the absence of
adequate antenatal care, including iron supplementation
and routine monitoring, causes such as anemia, thyro-
toxicosis, peripartum cardiomyopathy, and hyperten-
sion-induced heart disease become significant targets for
heart failure redistribution [36-40]. Increased cardiac
work in pregnancy will expose underlying cardiac condi-
tions, such as congenital heart anomalies and rheumatic
valve disease, which were less likely to have been diag-
nosed prior to pregnancy in developing countries [41].
This improved understanding of the underlying causes
of heart failure deaths will enable clinicians and policy-
makers to better care for this vulnerable population.
There are several limitations of the model to consider.
First, the ap r i o r iconceptual target list for the regres-
sion only includes targets that are pathophysiologically
plausible causes of heart failure. There is no evidence to
conclude that clinicians exclusively miscode heart failure
deaths from pathophysiologically related underlying
causes. The assumption regarding this issue is high-
lighted in Table 3, step 1. Additional file 1 lists the per-
cent I50.9 (heart failure, unspecified) of all heart failure-
attributed deaths, which may have a higher probability
of being nonpathophysiologically related and thus would
violate our assumption. Of note, there is a large varia-
tion in the percent I50.9 across countries [5.3-99.9%],
and the average percent 150.9 in developed countries
[54.6%] is roughly equivalent to that for developing
countries [51.8%]. A recent paper by Stevens et al pro-
poses a coarsened exact matching method to redistri-
bute heart failure that includes nonpathophysiologically-
related causes [42]. Future work could utilize this
matching method to select targets for the regression
method proposed in the paper. Second, as noted in
T a b l e3 ,s t e p4 ,w ea s s u m et h a td e a t h sc o d e dt ot h e
defined underlying causes of heart failure have been cor-
rectly assigned. Third, there exists no gold standard with
which to validate the results of the model. Field studies,
such as the Puffer method, may offer some degree of
validation [43]. However, even with a wide-scale autopsy
study, it would be difficult to ascertain the etiology of
heart failure-attributed deaths with certainty [16,44].
Finally, as highlighted in Table 3, step 7, we have
assumed that the primary mortality datasets used in this
model do not require correction for completeness. Pre-
vious literature has noted that countries have varying
rates of data completeness and that correction for this
incompleteness may enhance the comparability of
national cause of death data [45]. When researchers or
policymakers seek to replicate this model, they are
encouraged to explore the completeness of their primary
Table 5 Rank changes, by cause (bolded if cause breaks into top 15), 2005
Ischemic heart disease rank Hypertensive heart disease rank COPD rank
Japan Males 3 –>1 4 6–>4 6 1 2–>1 2
Females 2 –>1 3 8–>3 8 3 2–>1 6
France Males 2 –>1 4 6–>4 6 1 2–>1 2
Females 2 –>1 2 8–>2 8 2 5–>1 6
Argentina Males 1 –>1 24 –>1 0 7 –>6
Females 3 –>1 16 –>6 1 8–>1 1
South Africa Males 5 –>4 16 –>1 2 7 –>7
Females 9 –>5 1 1–>1 0 1 3–>1 2
***Ranks of GBD-level causes by age-adjusted death rate in the pre- and post-heart failure redistribution datasets.
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rational interpretation of the results as found above is
sufficient to confirm that the model provides the most
viable method currently available to correct mortality
data for heart failure.
This work highlights the need to improve the quality
of death certification in all regions of the world. The
generation of empirical evidence regarding the accuracy
of death certification should be a future research prior-
ity. For example, field studies comparing registered
causes of death with diagnoses on medical records or
household-based verbal autopsies can shed some light
on this issue. On a practical level, as electronic health
records become increasingly utilized across the globe,
installing safeguards to prevent the use of garbage codes
in death certification is critical. Finally, educating health
professionals to more accurately code underlying causes
of death must be an essential component of any health
system reform. This can be accomplished by not only
providing better diagnostic tools and educating profes-
sionals about how to accurately certify deaths, but also
by inspiring ownership and engagement in the crucial
role of death certification in defining a health policy
agenda.
Conclusions
Despite an increase in both the quantity and quality of
heart failure treatment modalities in recent years, mor-
tality due to heart failure persists at a high rate [46].
This reality makes prevention efforts as well as early
detection and treatment of the underlying conditions
that lead to heart failure a top priority. The use of heart
failure as an underlying cause of death obscures the true
population causes of death, presenting a marked chal-
lenge to setting a health policy agenda that adequately
rises to this challenge. The method described herein is
systematic, replicable, and empirically based, allowing
policymakers to maximize the use of available mortality
data to determine these underlying causes of heart fail-
ure. Ultimately, this will enable policymakers to make
more informed decisions regarding priority health inter-
ventions and resource allocation and thus hone the glo-
bal response to the rising cardiovascular epidemic that
has thus far been inadequate.
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